Advertisement

Colfax Corporation CFX

Set alert

Price alert · CFX

All alert types
39.06 0.00 0.00%

At close

38.88 Day range 40.67

52-week range unavailable

Open
40.60
Prev close
39.06
Mkt cap
2.10B
Vol
2.95M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
38.88
High
40.67
Forward P/E
14.52
Beta
2.12
Short ratio
4.91
Inst. own
0.00%
Dividend
0.00
Ex-div date
Earnings
May 5, 2022
50-d avg
69.21
200-d avg
78.15
1y target
50.42

2Y chart

Chart tools
Interval

Events in this range
  • Nov 4, 2021Earnings: —; estimate 0.54; surprise —%
  • Jan 14, 2022Rating: Morgan Stanley · — → Equal-Weight
  • Jan 28, 2022Rating: Morgan Stanley · — → Equal-Weight
  • Feb 8, 2022Downgrade: Seaport Global · Buy → Neutral
  • Feb 22, 2022Earnings: —; estimate 0.57; surprise —%
  • Feb 23, 2022Rating: Stifel · — → Buy
  • Mar 15, 2022Rating: Keybanc · — → Overweight
  • Mar 15, 2022Rating: Morgan Stanley · — → Equal-Weight
Signals (15)
NameDateAgo
SMA: BearishApr 4, 20224 years ago
SMA: BullishApr 1, 20224 years ago
SMA: BearishMar 30, 20224 years ago
SMA: BullishMar 29, 20224 years ago
MACD: Buy SignalMar 16, 20224 years ago
RSI: OversoldMar 7, 20224 years ago
MACD: Sell SignalMar 1, 20224 years ago
MACD: Buy SignalFeb 8, 20224 years ago
RSI: OversoldJan 26, 20224 years ago
MACD: Sell SignalJan 20, 20224 years ago
MACD: Buy SignalDec 21, 20214 years ago
MACD: Sell SignalDec 20, 20214 years ago
RSI: OversoldDec 16, 20214 years ago
RSI: OversoldDec 13, 20214 years ago
RSI: OversoldNov 26, 20214 years ago

Key statistics

Market cap
2.10B
Enterprise value
5.39B
Trailing P/E
28.55
Forward P/E
14.52
PEG ratio
1.13
Price / sales
0.54
Price / book
0.44
EPS (TTM)
1.37
Beta
2.12
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
1.86%
Revenue (TTM)
3.85B
Revenue growth
23.60%
Free cash flow
264.89M
Total cash
719.37M
Total debt
2.27B
Return on equity
2.39%
Shares outstanding
53.78M
Short % of float
5.57%
50-day average
69.21
200-day average
78.15

Analyst view

Consensus: buy

Buy
Price target (mean) 50.42 +29.1% upside
Target (low)
37.00
Target (mean)
50.42
Target (high)
65.00
Ratings (0m) 17 8 buy · 8 hold · 1 sell
  • Strong buy4
  • Buy4
  • Hold8
  • Sell0
  • Strong sell1

Next earnings

May 5, 2022

Expected May 5, 2022. Consensus EPS estimate 0.52.

Earnings history

Earnings

CFX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
May 5, 2022Mar 1, 20220.49———
Feb 22, 2022Dec 1, 20210.57———
Nov 4, 2021Sep 1, 20210.54———
Jul 28, 2021Jun 1, 20210.53———
Apr 29, 2021Mar 1, 20210.39———
Feb 18, 2021Dec 1, 20200.49———

Upgrades / downgrades

CFX analyst upgrades and downgrades
DateFirmActionFromTo
Mar 15, 2022Morgan Stanleymain—Equal-Weight
Mar 15, 2022Keybancmain—Overweight
Feb 23, 2022Stifelmain—Buy
Feb 8, 2022Seaport GlobaldownBuyNeutral
Jan 28, 2022Morgan Stanleymain—Equal-Weight
Jan 14, 2022Morgan Stanleymain—Equal-Weight

About Colfax Corporation

Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.

Sector
Industrials
Industry
Specialty Industrial Machinery
Country
United States

News

Your note

Sign in to keep a note on CFX — it syncs with the Stock Master app.

Insider holders

CFX insider holders
InsiderRelationLatest transactionDateShares held
ALLENDER PATRICK WDirectorStock Award(Grant)Dec 30, 2021291,055
HIX CHRISTOPHER MChief Financial OfficerSaleFeb 28, 2022143,417
KAMBEYANDA SHYAMOfficerSaleMar 6, 2022100,985
LANG PATRICIA AOfficerSaleMar 6, 202233,105
PITTS DOUGLAS JOfficerSaleFeb 27, 20229,032
PRYOR DANIEL AOfficerSaleMar 6, 2022205,487
Advertisement